• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

For Industry

  • Print
  • Share
  • E-mail


Animal Drug User Fee Act of 2003 (ADUFA) Public Meeting

Center for Veterinary Medicine
7519 Standish Place, Meeting Room A, 3rd Floor
Rockville, MD 20855

April 24, 2007
9:00 am

The FDA’s Center for Veterinary Medicine (CVM) will hold a public meeting on the Animal Drug User Fee Act of 2003 (ADUFA) to seek public comments relative to ADUFA’s overall performance and reauthorization as directed by Congress.

The meeting will be held Tuesday, April 24, 2007, in Meeting Room A third floor, at 7519 Standish Place, Rockville, MD 20855. 

As directed by Congress, FDA is holding a public meeting to gather information on what CVM should consider to including in the reauthorization of ADUFA and hear stakeholder views on this subject.

CVM offers two questions for consideration, and is interested in stakeholder responses and any other pertinent information.

  1. What is your assessment of the overall performance of the ADUFA program thus far?
  2. What suggestions or changes would you make relative to the reauthorization of ADUFA?

CVM has published a number of reports that may help inform the public about the ADUFA program. Key documents such as ADUFA-related guidance, legislation, performance reports, and financial reports, are posted on the CVM ADUFA Page at

Registration is strongly encouraged due to building security requirements and limited meeting space. The Registration Form (see below) should be submitted no later than one day in advance of the meeting, or April 23, 2007.

Written comments should be submitted to the Division of Dockets Management (HFA-305), identified with the docket number 2007N-0069 , Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Electronic comments may be submitted to the Docket Management Branch at the following site: http://www.fda.gov/dockets/ecomments. Submit a single copy of electronic comments or two paper copies of any written comments (individuals may submit one paper copy). The docket will remain open for written comments through May 24, 2007, 30 days following the meeting. Comments may be reviewed in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday

For additional information, please contact Aleta Sindelar, Office of the Director (HFV-3), Center for Veterinary Medicine, Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-276-9004, FAX 240-276-9020, e-mail aleta.sindelar@fda.hhs.gov.